Prophylactic Vancomycin Leads to Fewer Device Removals in Sacral Neuromodulation
Vancomycin as a prophylactic antibiotic was associated with fewer device removals compared to most antibiotics in this retrospective cohort analysis. While prospective trials could confirm this benefit, low removal rates may make this impractical.
Authors
- Gary Sutkin (ORCID: https://orcid.org/0000-0002-6336-5109)
- Jonathan P. Shepherd (ORCID: https://orcid.org/0000-0002-7038-1625)
- Jada A. Ohene-Agyei
- An‐Lin Cheng (ORCID: https://orcid.org/0000-0002-8441-5566)
- Xi Wang (ORCID: https://orcid.org/0000-0002-0322-5577)
- Suman Sahil
Institutions
- University of Missouri–Kansas City (US)
- UConn Health (US)
Publication Details
- Journal
- Urogynecology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1097/spv.0000000000001606
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.37